Tesla, Inc.'s Q2 2025 results reveal declining deliveries, revenue, and margins amid rising competition. Click for my updated ...

Tesla, Inc.'s declining revenues, weak demand, and overvaluation signal challenges ahead. Discover why it tops the short list ...

I recently interviewed investor and author Daniel Rasmussen for The Long View podcast, where he commented that “value hasn’t worked in the U.S., but it’s worked fine internationally.” ...

Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ...